Natixis Investment Managers International - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.86 and the average weighting 0.5%.

Quarter-by-quarter ownership
Natixis Investment Managers International ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2015$213,000
-45.9%
27,258
-58.1%
0.03%
-48.1%
Q4 2014$394,000
+363.5%
64,992
+224.6%
0.05%
+333.3%
Q3 2014$85,000
-31.5%
20,0220.0%0.01%
-25.0%
Q2 2014$124,000
-4.6%
20,0220.0%0.02%
-11.1%
Q1 2014$130,00020,0220.02%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 3,000,000$5,160,0004.58%
Foresite Capital Management II, LLC 6,225,049$10,707,0003.59%
Scale Management, LLC 1,312,575$2,258,0003.46%
NEA Management Company, LLC 3,709,000$6,379,0000.41%
Cheyne Capital Management (UK) LLP 413,200$709,0000.38%
Rhenman & Partners Asset Management AB 1,189,000$2,045,0000.31%
SAMLYN CAPITAL, LLC 6,160,417$10,596,0000.22%
Rock Springs Capital Management LP 1,650,000$2,838,0000.22%
Palo Alto Investors LP 1,673,024$2,878,0000.16%
GLOBEFLEX CAPITAL L P 295,000$507,0000.14%
View complete list of OREXIGEN THERAPEUTICS INC shareholders